Literature DB >> 21213005

Extreme hypercomplementemia in the setting of mixed cryoglobulinemia.

Bharath Manu Akkara Veetil1, Thomas G Osborn, Dean F Mayer.   

Abstract

Elevated levels of complement components, C3 and C4, are often seen in inflammatory diseases. They are generally not thought to be responsible for organ injury but simply reflect stimulation of the immune system. Extremely high elevations of these components are rarely seen. Such values are usually reported in patients with hematopoietic malignancies. We report here a case of C3 elevation to 9.22 g/L (5 times the upper limit of normal) and C4 elevation to 2.48 g/L (6 times the upper limit of normal). To our knowledge, no prior elevations of this magnitude have been reported previously from our institution or in the published medical literature (+/- MEDLINE search, using keywords hypercomplementemia, C3, C4, and lymphoplasmacytic lymphoma). In this case, there appeared to be no adverse end-organ damage from the excessive complement components or their activation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21213005     DOI: 10.1007/s10067-010-1652-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  18 in total

Review 1.  Synthesis of complement components by synovial membrane.

Authors:  K Whaley; D Guc; P Gulati; D Lappin
Journal:  Immunopharmacology       Date:  1992 Sep-Oct

2.  In vitro synthesis of immunoglobulins, secretory component, complement and lysozyme by human gastrointestinal tissues. I. Normal tissues.

Authors:  R F Lai A Fat; D B McClelland; R van Furth
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

3.  Cryoglobulinemia based on interaction between a gamma macroglobulin and 7S gamma globulin.

Authors:  J LOSPALLUTO; B DORWARD; W MILLER; M ZIFF
Journal:  Am J Med       Date:  1962-01       Impact factor: 4.965

Review 4.  Complement in the pathophysiology of human disease.

Authors:  M M Frank
Journal:  N Engl J Med       Date:  1987-06-11       Impact factor: 91.245

5.  In vitro synthesis of immunoglobulins, secretory component and complement in normal and pathological skin and the adjacent mucous membranes.

Authors:  R F Lai a Fat; D Suurmond; R van Furth
Journal:  Clin Exp Immunol       Date:  1973-07       Impact factor: 4.330

6.  The complement system in essential mixed cryoglobulinemia.

Authors:  G Montagnino; A De Vecchi; P Scalia; M T Bajetta; A Tarantino
Journal:  Ric Clin Lab       Date:  1980 Jan-Mar

7.  Hypercomplementaemia as a marker of the evolution from benign to malignant B cell proliferation in patients with type II mixed cryoglobulinaemia.

Authors:  C Vitali; C Ferri; P Nasti; L La Civita; M Mazzantini; G Longombardo; S Bombardieri
Journal:  Br J Rheumatol       Date:  1994-08

8.  In vitro synthesis of some complement components (C1q, C3 and C4) by lymphoid tissues and circulating leucocytes in man.

Authors:  R F Lai A Fat; R van Furth
Journal:  Immunology       Date:  1975-02       Impact factor: 7.397

9.  Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia.

Authors:  A Corvetta; P J Spaeth; P A Ghirelli; F Orecchioni; R Buetler; M Montroni; U E Nydegger
Journal:  Diagn Immunol       Date:  1983

Review 10.  Rituximab in cryoglobulinaemic vasculitis, evidence for its effectivity: a case report and review of literature.

Authors:  Freke Wink; Pieternella M Houtman; Tim L Th A Jansen
Journal:  Clin Rheumatol       Date:  2010-10-31       Impact factor: 3.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.